Collaborative and support oriented work has over the past year had an impact in the study, and on the understanding, of a spectrum of diseases and disease processes such as cardiovascular disease (atherosclerosis), inflammatory respiratory disease, obesity and type II diabetes, inflammatory and immune-mediated renal disease, gene expression and gene regulation, axial skeletal development and transgenerational effects of diet restriction. To keep the clinical laboratory up-to-date, new methods and instruments have been obtained. For example, An Aperio Scan Scope has been added for digital imaging and imaging analysis of tissue sections. A CellCut laser microdissection scope (Molecular Machines and Industries) has been incorporated for the targeting and capture of specific cells or cell populations. Additionally, a SECTOR Imager 2400 by Meso Scale Discovery was obtained for the performance of a variety of serum biomarkers, in single- or multi-plex fashion, including, but not limited to, troponin T and I, fatty acid binding protein 3, inflammatory cytokines (e.g., interlukins, TNFa, INFg), growth factors (e.g., VEGF), hormones (e.g., insulin, leptin, etradiol, progeterone, testosterone).
Showing the most recent 10 out of 21 publications
